Viral dynamics in HIV-1 infection.

We thank Alan Perelson for a critical reading of the manuscript. This work was supported by NIH grant AI28108.

• Publication year

  1998

• Venue

  Cell

• Publication date

  1998-05-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0092-8674(00)81427-0PMID 9630210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV entry and its inhibition.

  1998cited by this paper
• Chemokine receptors: keys to AIDS pathogenesis?

  1998cited by this paper
• Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.

  1998cited by this paper
• HIV-1 auxiliary proteins: making connections in a dying cell.

  1998cited by this paper
• Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.

  1997cited by this paper
• Decay characteristics of HIV-1-infected compartments during combination therapy

  1997cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.

  1997cited by this paper
• Dynamics of HIV-1 and CD4+ lymphocytes in vivo.

  1997cited by this paper
• Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

  1997cited by this paper
• Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

  1997cited by this paper
• Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

  1997cited by this paper
• Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

  1997cited by this paper
• Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

  1997cited by this paper
• T cell turnover in HIV-1 disease.

  1997cited by this paper
• Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

  1997cited by this paper
• Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

  1996cited by this paper
• HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time

  1996cited by this paper
• Replication of HIV-1 in Dendritic Cell-Derived Syncytia at the Mucosal Surface of the Adenoid

  1996cited by this paper
• Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue

  1996cited by this paper
• In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

  1995cited by this paper
• Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro

  1995cited by this paper
• HIV-1 dynamics in vivo.

  1995cited by this paper
• Follicular dendritic cells and human immunodeficiency virus infectivity.

  1995cited by this paper
• Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

  1995cited by this paper
• HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

  1995cited by this paper
• Altered representation of naive and memory CD8 T cell subsets in HIV-infected children.

  1995cited by this paper
• HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo.

  1995cited by this paper
• Follicular dendritic cells and human immunodeficiency virus infectivity

  1995cited by this paper
• In vivo estimates of division and death rates of human T lymphocytes.

  1995cited by this paper
• Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

  1995cited by this paper
• Viral dynamics in human immunodeficiency virus type 1 infection

  1995cited by this paper
• Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1.

  1994cited by this paper
• HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

  1993cited by this paper
• Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

  1993cited by this paper
• High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

  1993cited by this paper
• Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.

  1992cited by this paper
• Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1.

  1992cited by this paper
• Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.

  1992cited by this paper
• Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis

  1992cited by this paper
• Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency

  1992cited by this paper
• Lymphoid organs function as major reservoirs for human immunodeficiency virus.

  1991cited by this paper
• Molecular basis of latency in pathogenic human viruses.

  1991cited by this paper
• Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.

  1991cited by this paper
• Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.

  1991cited by this paper
• HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

  1990cited by this paper
• Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

  1990cited by this paper
• Origin and turnover of monocytes and macrophages.

  1989cited by this paper
• Origin and turnover of monocytes and macrophages.

  1989cited by this paper
• Plasma viremia in human immunodeficiency virus infection.

  1989cited by this paper
• Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.

  1989cited by this paper
• The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4.

  1989cited by this paper
• Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

  1989cited by this paper
• HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation.

  1988cited by this paper
• Infection of monocyte/macrophages by human T lymphotropic virus type III.

  1986cited by this paper
• The role of mononuclear phagocytes in HTLV-III/LAV infection.

  1986cited by this paper
• In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).

  1986cited by this paper

• Apollo: a comprehensive GPU-powered within-host simulator for viral evolution and infection dynamics across population, tissue, and cell

  2025cites this paper
• Viral Evolution Under Physical Constraints: Decay, Mutation, and Transmission as a Constrained Optimization Problem

  2025cites this paper
• Revisiting the classical target cell limited dynamical within-host HIV model - Basic mathematical properties and stability analysis.

  2024cites this paper
• Machine Learning Bolsters Evidence That D1, Nef, and Tat Influence HIV Reservoir Dynamics

  2024cites this paper
• Apollo: A comprehensive GPU-powered within-host simulator for viral evolution and infection dynamics across population, tissue, and cell

  2024cites this paper
• Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease

  2024influential citation
• Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease

  2024cites this paper
• Mathematical Modeling of HIV Replication and the Response of the Interferon System

  2023cites this paper
• Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure

  2023cites this paper
• Scramblases and virus infection

  2022cites this paper
• NUMERICAL SOLUTION FOR HIV INFECTION OF CD4+T CELLS USING TAYLOR SERIES METHOD, RUNGE KUTTA AND ADAMS BASHFORTH METHOD

  2022cites this paper
• An assessment of the reproducibility of reverse transcription digital PCR quantification of HIV-1.

  2021cites this paper
• Elevated Numbers of HIV-Specific Poly-Functional CD8+ T Cells With Stem Cell-Like and Follicular Homing Phenotypes in HIV-Exposed Seronegative Individuals

  2021cites this paper
• Cellular determinants of HIV ‐ 1 persistence

  2020cites this paper
• SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in ‘lasso’ for the multi-faced virus

  2020cites this paper
• Modeling of the HIV-1 Life Cycle in Productively Infected Cells to Predict Novel Therapeutic Targets

  2020cites this paper
• CMPK2 and BCL-G are associated with type 1 interferon–induced HIV restriction in humans

  2018cites this paper
• Organs from deceased donors with false‐positive HIV screening tests: An unexpected benefit of the HOPE act

  2018cites this paper
• Roy, Priti Kumar and Chatterjee, Amar Nath and Greenhalgh, David and Khan, Qamar J A (2013) Long term dynamics in a mathematical model of HIV-1 infection with delay in different variants of the basic drug therapy

  2018cites this paper
• Rebound Relationships: An Investigation of HIV-1 Rebound Dynamics and Host Immune Responses During Analytical Treatment Interruption

  2018cites this paper
• Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons

  2018cites this paper
• Generation of HIV-Resistant Macrophages from IPSCs by Using Transcriptional Gene Silencing and Promoter-Targeted RNA

  2018cites this paper
• Oncolytic Viruses as a Potential Approach to Eliminate Cells That Constitute the Latent HIV Reservoir

  2018cites this paper
• Cellular Determinants of HIV Persistence on Antiretroviral Therapy.

  2018cites this paper
• On Discretization Method for Optimization Control Model for The Treatment of Pathogenic Induced HIV Infection

  2017cites this paper
• Effects of HIV infection on CD4+ T-cell population based on a fractional-order model

  2017cites this paper
• INVERSE PROBLEMS OF IMMUNOLOGY AND EPIDEMIOLOGY

  2017cites this paper
• Molecular modeling of viral nucleocapsid protein Zn fingers modulators

  2016cites this paper
• Efavirenz versus Nevirapina : comparação da efectividade e do perfil de segurança, a longo prazo, no tratamento da infecção por vírus da imunodeficiência humana tipo 1

  2016cites this paper
• NUMERICAL AND BIFURCATIONS ANALYSIS FOR MULTI-ORDER FRACTIONAL MODEL OF HIV INFECTION OF CD 4 + T-CELLS

  2016cites this paper
• Agent-Based Modelling applied to 5D model of the HIV infection

  2016cites this paper
• The role of exosomes and microRNA in Astrocyte-mediated HIV-1 Tat neurotoxicity

  2016cites this paper
• On Analysis of Parameter Estimation Model for the Treatment of Pathogen-Induced HIV Infectivity

  2016cites this paper
• SERONEGATIVE CONVERSION OF AN HIV POSITIVE SUBJECT TREATED WITH NIGELLA SATIVA AND HONEY

  2015cites this paper
• Impact of amino acid side chain fluorination on proteolytic stability of peptides

  2015cites this paper
• Variation of Human Immunodeficiency Virus Type-1 Reverse Transcriptase within the Simian Immunodeficiency Virus Genome of RT-SHIV

  2014cites this paper
• Backward bifurcation in a mathematical model for HIV infection in vivo with anti-retroviral treatment

  2014cites this paper
• Microbicide Intravaginal Rings

  2014cites this paper
• Microdevices for examining immunological responses of single cells to HIV

  2014cites this paper
• One Step Closer to HIV Eradication?

  2014cites this paper
• The apoptotic potential of different HIV-1 subtype C Tat mutations in cell culture

  2013cites this paper
• Modeling the within-host dynamics of HIV infection

  2013cites this paper
• Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.

  2013cites this paper
• Long term dynamics in a mathematical model of HIV-1 infection with delay in different variants of the basic drug therapy model

  2013cites this paper
• Contribution of Follicular Dendritic Cells to Persistent HIV Viremia

  2013cites this paper
• Nigella sativa concoction induced sustained seroreversion in HIV patient.

  2013influential citation
• ANTIRETROVIRAL DRUGS TOXICITY AND IMMUNE STATUS OF HIV PATIENTS UNDER COMPREHENSIVE CARE IN EMBU, KENYA

  2013cites this paper
• Human immunodeficiency virus type-1 (HIV-1) genetic diversity and prevalence of antiretroviral drug resistance mutations in treatment-naïve adults in Jos, North Central Nigeria

  2013cites this paper
• Cell-associated HIV RNA: a dynamic biomarker of viral persistence

  2013cites this paper
• Immune activation and HIV persistence: implications for curative approaches to HIV infection

  2013cites this paper
• Human immunodeficiency virus type-1 (HIV-1) genetic diversity and prevalence of antiretroviral drug resistance mutations in treatment-naïve adults in Jos, North Central Nigeria

  2013cites this paper
• Virtual Screening of Novel HIV-RT Inhibitors using Zinc Database

  2013cites this paper
• Screening ZINC database for novel HIV-1 reverse transcriptase Inhibitors

  2012cites this paper
• HIV-1 Nef Enhances Dendritic Cell-Mediated Viral Transmission to CD4+ T Cells and Promotes T-Cell Activation

  2012cites this paper
• Usefulness of proviral DNA of human immunodeficiency virus type 1 in AIDS treatment decisions

  2012cites this paper
• HIV-1 Reservoirs and Latency: Critical Barriers and Clues for HIV / AIDS Cure

  2012influential citation
• Comparison of efficacy of stavudine and zidovudine on CD4 counts in triple drug therapy regimen in patients with HIV infection - a retrospective study.

  2012cites this paper
• Impact of Latently Infected Cells on Strain Archiving Within HIV Hosts

  2012cites this paper
• Initiation of Antiretroviral Therapy : Current Controversies in When and with What to Start

  2012cites this paper
• HIV therapy by a combination of broadly neutralizing antibodies in humanized mice

  2012cites this paper
• Herpes-zoster virus ophthalmicus as presenting sign of HIV disease

  2011cites this paper
• Mathematical Immunology of Infectious Diseases

  2011cites this paper
• HIV-1 and the macrophage

  2011cites this paper
• Host genetic effects on HIV-1 replication in macrophages

  2011cites this paper
• Characterisation, Evaluation and Clinical Significance of Latent HIV-1 Reservoirs and Therapeutic Strategies for HIV Eradication

  2011cites this paper
• PREDICTING THE PROBABILITY OF PERSISTENCE OF HIV INFECTION WITH THE STANDARD MODEL

  2011cites this paper
• Immune Activation, Cd4+ T Cell Counts, and Viremia Exhibit Oscillatory Patterns over Time in Patients with Highly Resistant HIV Infection

  2011cites this paper
• Exploring the impact of heterogeneities on HIV dynamics within host

  2011cites this paper
• Anti-HIV therapy: pipeline approaches and future directions.

  2011cites this paper
• Characterization of HIV-1 pol sequences in newly HIV-1 diagnosed patients: identification of drug resistance markers and their involvement in the transmission events

  2010cites this paper
• In Vivo Validation of a Bioinformatics Based Tool to Identify Reduced Replication Capacity in HIV-1

  2010cites this paper
• Optimal Control Strategy for a Fully Determined HIV Model

  2010cites this paper
• Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy

  2009cites this paper
• Pharmaceutical approaches to eradication of persistent HIV infection

  2009cites this paper
• Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription.

  2009cites this paper
• Modeling HIV persistence, the latent reservoir, and viral blips.

  2009cites this paper
• HIV model with intracellular delay — a mathematical study

  2009cites this paper
• Stage-Dependent Inhibition of HIV-1 Replication by Antiretroviral Drugs in Cell Culture

  2009cites this paper
• Surveillance programs for detection and characterization of emergent pathogens and antimicrobial resistance: results from the Division of Infectious Diseases, UNIFESP.

  2009cites this paper
• Human immunodeficiency virus.

  2009cites this paper
• Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle

  2008cites this paper
• Factors controlling chromatin organization and nucleosome positioning for establishment and maintenance of HIV latency.

  2008cites this paper
• Mathematical modeling of antigenicity for HIV dynamics

  2008cites this paper
• Identifiability Problems of Time-delay HIV Models

  2008cites this paper
• Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection.

  2008cites this paper
• HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission

  2008cites this paper
• Modelling the co-infection dynamics of HIV-1 and M. tuberculosis

  2008cites this paper
• Etude comparative des thérapies anti-VIH : rôle des transporteurs d'efflux sur le passage transmembranaire des antirétroviraux au niveau des cellules CD4+ et de la barrière hémato-encéphalique

  2008cites this paper
• Mathematical modelling of biosystems

  2008cites this paper
• Optimierung genetischer, auf Rezeptorvermittelter Antigenaufnahme beruhender Impfstrategien

  2008cites this paper
• Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys.

  2008cites this paper
• A mathematical model for HIV dynamics

  2008cites this paper
• Hide-and-seek: the challenge of viral persistence in HIV-1 infection.

  2008cites this paper
• Mathematical Modeling of HIV-1 Infection and Drug Therapy

  2008cites this paper
• Nanopharmaceutical for improved anti-HIV therapy

  2007cites this paper
• Determinació de l’activitat antiviral de nous compostos inhibidors del VIH-1

  2007cites this paper
• Pharmacokinetics, Toxicity, and Functional Studies of the Selective Kv1.3 Channel Blocker 5-(4-Phenoxybutoxy)Psoralen in Rhesus Macaques

  2007cites this paper
• 21 – VIH/sida

  2007cites this paper
• Suv39H1 and HP1γ are responsible for chromatin‐mediated HIV‐1 transcriptional silencing and post‐integration latency

  2007cites this paper
• Chronic CD4+ T-Cell Activation and Depletion in Human Immunodeficiency Virus Type 1 Infection: Type I Interferon-Mediated Disruption of T-Cell Dynamics

  2007cites this paper